C. Dedieu, H. Chanvrier, J. Carr-Klappert, A. Batista Mesquita Sauvage, S. Manciana, B. Van Meenen, M. Cote, T. Corbière, H. Auner, F. Solly, M. Eicher
{"title":"瑞士血液病患者的教育需求:关注血液学实验室结果和生物医学概念方面的知识","authors":"C. Dedieu, H. Chanvrier, J. Carr-Klappert, A. Batista Mesquita Sauvage, S. Manciana, B. Van Meenen, M. Cote, T. Corbière, H. Auner, F. Solly, M. Eicher","doi":"10.1002/hon.70093_ON08","DOIUrl":null,"url":null,"abstract":"<p>C. Dedieu, H. Chanvrier, and F. Solly equally contributing author.</p><p><b>Introduction:</b> Patients with hematological diseases, including blood cancers such as lymphoma or myeloma, often face significant difficulties in navigating health information about their illness due to the complexity of these conditions.</p><p>One of the self-reported educational needs of patients with hematological cancer is receiving clear and comprehensive information about laboratory results. Although these patients often undergo procedures such as venipuncture, knowledge gaps regarding laboratory results and biological concepts have been highlighted.</p><p>However, repeated procedures in combination with knowledge gaps and lack of information tailoring regarding laboratory results can decrease patient adherence and increase anxiety.</p><p>Our aim is to assess hematology patients’ knowledge of laboratory results and biological concepts, and their educational needs (format and frequency). We are also investigating patients’ interest in a novel biomedical consultation.</p><p><b>Methods:</b> This cross-sectional study is based on a digital self-reported questionnaire. Inpatients and outpatients over 18 years of age with a hematological disease and their caregivers are recruited at the Lausanne University Hospital by direct approach, flyers, patient associations or mail. The sample size of 103 was determined using Cochran’s formula, referencing a similar study. The questionnaire is divided into four sections consisting of (i) demographic information, (ii) general health literacy and disease awareness, (iii) preferences for educational interventions, and (iv) patient self-efficacy in managing laboratory results/biomedical information.</p><p><b>Results:</b> Preliminary results were obtained from 36 patients between November and December 2024. The largest group of participants were aged 60–75 years (42%), followed by those aged 75 years or older (25%). Patients with lymphoma and myeloma represented 5.6% and 22% of the participants respectively. Most participants (56%) rated their knowledge of biological concepts as average or poor. Only 19% of participants reported having a good understanding of blood counts. Understanding technical language and the meaning of laboratory results for their health was challenging according to 69%. Most participants (67%) expressed a desire to receive additional information regarding their laboratory results while 50% were interested in an individual educational biomedical consultation about laboratory analyses.</p><p><b>Conclusion:</b> These preliminary results provide valuable insights into patients' knowledge, unmet educational needs and preferences regarding educational formats. Recruitment is still ongoing, and we aim to present the final results at the conference. Our study will ultimately contribute to the development of an educational intervention to improve patients’ knowledge and self-management of laboratory results. Further steps will be to adapt the intervention to the characteristics of the patients to provide personalized, tailored educational support.</p><p><b>Keywords:</b> Patient and Family-centered Care</p><p><b>Potential sources of conflict of interest:</b></p><p><b>M. Eicher</b></p><p><b>Consultant or advisory role:</b> ME's institution received payment by Roche for her activities in an advisory board</p><p><b>Other remuneration:</b> ME’s institution received payment for presentation and lectures given by her from Roche, BMS and Vifor</p>","PeriodicalId":12882,"journal":{"name":"Hematological Oncology","volume":"43 S3","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.70093_ON08","citationCount":"0","resultStr":"{\"title\":\"EDUCATIONAL NEEDS OF SWISS PATIENTS WITH HEMATOLOGICAL DISEASES: FOCUS ON KNOWLEDGE REGARDING HEMATOLOGY LABORATORY RESULTS AND BIOMEDICAL CONCEPTS\",\"authors\":\"C. Dedieu, H. Chanvrier, J. Carr-Klappert, A. Batista Mesquita Sauvage, S. Manciana, B. Van Meenen, M. Cote, T. Corbière, H. Auner, F. Solly, M. Eicher\",\"doi\":\"10.1002/hon.70093_ON08\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>C. Dedieu, H. Chanvrier, and F. Solly equally contributing author.</p><p><b>Introduction:</b> Patients with hematological diseases, including blood cancers such as lymphoma or myeloma, often face significant difficulties in navigating health information about their illness due to the complexity of these conditions.</p><p>One of the self-reported educational needs of patients with hematological cancer is receiving clear and comprehensive information about laboratory results. Although these patients often undergo procedures such as venipuncture, knowledge gaps regarding laboratory results and biological concepts have been highlighted.</p><p>However, repeated procedures in combination with knowledge gaps and lack of information tailoring regarding laboratory results can decrease patient adherence and increase anxiety.</p><p>Our aim is to assess hematology patients’ knowledge of laboratory results and biological concepts, and their educational needs (format and frequency). We are also investigating patients’ interest in a novel biomedical consultation.</p><p><b>Methods:</b> This cross-sectional study is based on a digital self-reported questionnaire. Inpatients and outpatients over 18 years of age with a hematological disease and their caregivers are recruited at the Lausanne University Hospital by direct approach, flyers, patient associations or mail. The sample size of 103 was determined using Cochran’s formula, referencing a similar study. The questionnaire is divided into four sections consisting of (i) demographic information, (ii) general health literacy and disease awareness, (iii) preferences for educational interventions, and (iv) patient self-efficacy in managing laboratory results/biomedical information.</p><p><b>Results:</b> Preliminary results were obtained from 36 patients between November and December 2024. The largest group of participants were aged 60–75 years (42%), followed by those aged 75 years or older (25%). Patients with lymphoma and myeloma represented 5.6% and 22% of the participants respectively. Most participants (56%) rated their knowledge of biological concepts as average or poor. Only 19% of participants reported having a good understanding of blood counts. Understanding technical language and the meaning of laboratory results for their health was challenging according to 69%. Most participants (67%) expressed a desire to receive additional information regarding their laboratory results while 50% were interested in an individual educational biomedical consultation about laboratory analyses.</p><p><b>Conclusion:</b> These preliminary results provide valuable insights into patients' knowledge, unmet educational needs and preferences regarding educational formats. Recruitment is still ongoing, and we aim to present the final results at the conference. Our study will ultimately contribute to the development of an educational intervention to improve patients’ knowledge and self-management of laboratory results. Further steps will be to adapt the intervention to the characteristics of the patients to provide personalized, tailored educational support.</p><p><b>Keywords:</b> Patient and Family-centered Care</p><p><b>Potential sources of conflict of interest:</b></p><p><b>M. Eicher</b></p><p><b>Consultant or advisory role:</b> ME's institution received payment by Roche for her activities in an advisory board</p><p><b>Other remuneration:</b> ME’s institution received payment for presentation and lectures given by her from Roche, BMS and Vifor</p>\",\"PeriodicalId\":12882,\"journal\":{\"name\":\"Hematological Oncology\",\"volume\":\"43 S3\",\"pages\":\"\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.70093_ON08\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematological Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/hon.70093_ON08\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematological Oncology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hon.70093_ON08","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
C. Dedieu, H. Chanvrier和F. Solly都是贡献作者。导读:血液学疾病患者,包括血癌如淋巴瘤或骨髓瘤,由于这些疾病的复杂性,在浏览有关其疾病的健康信息时经常面临重大困难。血液病患者自我报告的教育需求之一是获得关于实验室结果的清晰和全面的信息。虽然这些患者经常接受诸如静脉穿刺之类的手术,但关于实验室结果和生物学概念的知识差距已经突出。然而,重复的程序加上知识差距和缺乏关于实验室结果的信息定制可能会降低患者的依从性并增加焦虑。我们的目的是评估血液病患者对实验室结果和生物学概念的知识,以及他们的教育需求(格式和频率)。我们也在调查患者对新型生物医学咨询的兴趣。方法:本横断面研究基于数字自我报告问卷。洛桑大学医院通过直接接触、传单、患者协会或邮件等方式招募18岁以上的血液病住院和门诊患者及其护理人员。103个样本的大小是根据科克伦公式确定的,参考了一个类似的研究。问卷分为四个部分,包括:(i)人口统计信息,(ii)一般卫生知识和疾病意识,(iii)对教育干预措施的偏好,以及(iv)患者在管理实验室结果/生物医学信息方面的自我效能。结果:2024年11 - 12月36例患者获得初步结果。最大的参与者群体是60-75岁(42%),其次是75岁及以上的人(25%)。淋巴瘤和骨髓瘤患者分别占参与者的5.6%和22%。大多数参与者(56%)认为他们对生物学概念的了解一般或较差。只有19%的参与者报告对血液计数有很好的了解。69%的人表示,理解技术语言和实验室结果对其健康的意义具有挑战性。大多数参与者(67%)表示希望获得有关其实验室结果的额外信息,而50%的人对有关实验室分析的个人教育生物医学咨询感兴趣。结论:这些初步结果为了解患者的知识、未满足的教育需求和对教育形式的偏好提供了有价值的见解。招聘仍在进行中,我们的目标是在会议上公布最终结果。我们的研究最终将有助于教育干预的发展,以提高患者对实验室结果的知识和自我管理。进一步的步骤将是使干预措施适应患者的特点,以提供个性化的、量身定制的教育支持。关键词:以病人和家庭为中心的护理潜在的利益冲突来源:M。顾问或顾问角色:ME所在机构因其在咨询委员会的活动而获得罗氏公司的报酬。其他报酬:ME所在机构因其在罗氏、BMS和Vifor的演讲和讲座而获得报酬
EDUCATIONAL NEEDS OF SWISS PATIENTS WITH HEMATOLOGICAL DISEASES: FOCUS ON KNOWLEDGE REGARDING HEMATOLOGY LABORATORY RESULTS AND BIOMEDICAL CONCEPTS
C. Dedieu, H. Chanvrier, and F. Solly equally contributing author.
Introduction: Patients with hematological diseases, including blood cancers such as lymphoma or myeloma, often face significant difficulties in navigating health information about their illness due to the complexity of these conditions.
One of the self-reported educational needs of patients with hematological cancer is receiving clear and comprehensive information about laboratory results. Although these patients often undergo procedures such as venipuncture, knowledge gaps regarding laboratory results and biological concepts have been highlighted.
However, repeated procedures in combination with knowledge gaps and lack of information tailoring regarding laboratory results can decrease patient adherence and increase anxiety.
Our aim is to assess hematology patients’ knowledge of laboratory results and biological concepts, and their educational needs (format and frequency). We are also investigating patients’ interest in a novel biomedical consultation.
Methods: This cross-sectional study is based on a digital self-reported questionnaire. Inpatients and outpatients over 18 years of age with a hematological disease and their caregivers are recruited at the Lausanne University Hospital by direct approach, flyers, patient associations or mail. The sample size of 103 was determined using Cochran’s formula, referencing a similar study. The questionnaire is divided into four sections consisting of (i) demographic information, (ii) general health literacy and disease awareness, (iii) preferences for educational interventions, and (iv) patient self-efficacy in managing laboratory results/biomedical information.
Results: Preliminary results were obtained from 36 patients between November and December 2024. The largest group of participants were aged 60–75 years (42%), followed by those aged 75 years or older (25%). Patients with lymphoma and myeloma represented 5.6% and 22% of the participants respectively. Most participants (56%) rated their knowledge of biological concepts as average or poor. Only 19% of participants reported having a good understanding of blood counts. Understanding technical language and the meaning of laboratory results for their health was challenging according to 69%. Most participants (67%) expressed a desire to receive additional information regarding their laboratory results while 50% were interested in an individual educational biomedical consultation about laboratory analyses.
Conclusion: These preliminary results provide valuable insights into patients' knowledge, unmet educational needs and preferences regarding educational formats. Recruitment is still ongoing, and we aim to present the final results at the conference. Our study will ultimately contribute to the development of an educational intervention to improve patients’ knowledge and self-management of laboratory results. Further steps will be to adapt the intervention to the characteristics of the patients to provide personalized, tailored educational support.
Keywords: Patient and Family-centered Care
Potential sources of conflict of interest:
M. Eicher
Consultant or advisory role: ME's institution received payment by Roche for her activities in an advisory board
Other remuneration: ME’s institution received payment for presentation and lectures given by her from Roche, BMS and Vifor
期刊介绍:
Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:
-Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders
-Diagnostic investigations, including imaging and laboratory assays
-Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases
-Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies
-Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.
Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.